Literature DB >> 24615605

Surgical treatment of patients with mildly elevated parathormone and calcium levels.

Punam P Parikh1, Bassan J Allan, John I Lew.   

Abstract

BACKGROUND: Patients with mildly elevated parathormone (PTH) and calcium levels consistent for primary hyperparathyroidism (pHPT) may present with more underlying multiglandular disease (MGD) and higher operative failure and recurrence rates than those with conventional, or "classic" pHPT. This study compared the clinical characteristics and surgical outcomes of patients with biochemically mild versus conventional pHPT.
METHODS: A series of 707 consecutive patients underwent initial targeted parathyroidectomy with intraoperative parathormone monitoring (IPM) at a single institution. Biochemically mild (BM) pHPT was defined as PTH > 65 and <100 pg/ml with serum calcium >10.4 and <11 mg/dl. Conventional pHPT was defined as calcium ≥11 mg/dl and PTH ≥ 100 pg/ml. Prospectively collected data for all patients, including operative indication, preoperative laboratory values, imaging, IPM dynamics, and postoperative laboratory values were retrospectively reviewed. Additional assessments included presence of MGD, bilateral neck exploration (BNE), single-gland volume, and operative failure or success, and recurrence.
RESULTS: Of 60 patients with BM-pHPT, 46 reported preoperative bone pain, kidney stones, fatigue, and/or mental disturbances. The remaining 14 BM-pHPT patients underwent parathyroidectomy based on published asymptomatic guidelines. Patients with BM-pHPT had significantly more kidney stones, MGD, and BNE. Average single-gland volume and postoperative PTH levels were significantly lower in BM-pHPT patients. There were no significant differences between groups regarding preoperative localization accuracy, IPM dynamics, or operative success/failure, recurrence rates.
CONCLUSIONS: BM-pHPT patients had more MGD requiring BNE but achieved operative success rates similar to those of patients with conventional disease. IPM successfully identifies MGD in BM-pHPT patients, who should be counseled regarding more extensive operations than limited parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24615605     DOI: 10.1007/s00268-014-2487-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  New point-of-care intraoperative parathyroid hormone assay for intraoperative guidance in parathyroidectomy.

Authors:  Denise M Carneiro; George L Irvin
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  Surgery improves quality of life in patients with "mild" hyperparathyroidism.

Authors:  Joel T Adler; Rebecca S Sippel; Sarah Schaefer; Herbert Chen
Journal:  Am J Surg       Date:  2009-03       Impact factor: 2.565

4.  Familial hyperparathyroidism.

Authors:  T Christensson
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

5.  The predictive value of laboratory findings in patients with primary hyperparathyroidism.

Authors:  Géza Mózes; Kathleen J Curlee; Charles M Rowland; Jon A van Heerden; Geoffrey B Thompson; Clive S Grant; David R Farley
Journal:  J Am Coll Surg       Date:  2002-02       Impact factor: 6.113

6.  Hyperparathyroidism--epidemic or endemic? Diagnosis and treatment.

Authors:  C B Esselstyn; G Crile
Journal:  Cleve Clin Q       Date:  1970-04

7.  Primary hyperparathyroidism: changing clinical, surgical and pathologic aspects.

Authors:  R C Haff; W C Black; W F Ballinger
Journal:  Ann Surg       Date:  1970-01       Impact factor: 12.969

8.  Normal PTH levels in primary hyperparathyroidism: still the same disease?

Authors:  Amanda L Amin; Tracy S Wang; Thomas J Wade; Tina W F Yen
Journal:  Ann Surg Oncol       Date:  2011-05-03       Impact factor: 5.344

9.  Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.

Authors:  Clive S Grant; Geoffrey Thompson; David Farley; Jon van Heerden
Journal:  Arch Surg       Date:  2005-05

Review 10.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

View more
  2 in total

1.  Large standard deviation: think before you write.

Authors:  Pankaj Kumar Garg
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

2.  "Silent" kidney stones in "asymptomatic" primary hyperparathyroidism-a comparison of multidetector computed tomography and ultrasound.

Authors:  Andreas Selberherr; Marcus Hörmann; Gerhard Prager; Philipp Riss; Christian Scheuba; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2016-10-12       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.